The HDRS-17 will be used to screen out current depression, as characterized by a score of > 8. Administration of the HDRS will be repeated during and at the end of double-blind treatment. The MMSE, a brief measure of cognitive functioning that assesses arithmetic, memory and orientation, will screen out current cognitive impairment.